John Trojanowski, MD, PhD
John Q. Trojanowski, MD, PhD is remembered as a neuroscience pioneer.
Penn’s Gene Therapy Program signs manufacturing partnership with the Center for Breakthrough Medicines
The Center for Breakthrough Medicines and Penn’s Gene Therapy Program (GTP) entered into a multi-year collaboration focusing on the manufacturing and testing of modern gene therapy processes.
ŌNŌCOR launches ŌNŌ system
PCI startup ŌNŌCOR announced the first-in-human use of their ŌNŌ endovascular retrieval system for the removal of an intracardiac tumor.
Neuralert’s first product receives FDA Breakthrough Designation
Neuralert addresses the problem of late or undetected stroke in hospitalized patients.
Faculty Innovators are Celebrated
The 6th annual Celebration of Innovation returned in a hybrid format for 2021 with both attendees and award recipients participating in person and virtually.
Developing a chewing gum to reduce the incidence of Covid-19
A chewing gum impregnated with a plant-grown protein can serve as a “trap” for the SARS-CoV-2 virus, reducing viral load in the chewers saliva and potentially tamping down transmission.
Pennovation Works Celebrates Five Years
November 8, 2021 marked the fifth anniversary of Pennovation Works, Penn’s business incubator and laboratory space.
Interius BioTherapeutics Moves to Pennovation Lab
In October 2021, Interius BioTherapeutics (“Interius”) signed a 17,743 SF lease advancing cell and gene therapy research at the Pennovation Works innovation ecosystem.
Recupero Robotics launches
Dr. Johnson and a team of collaborators have launched Recupero Robotics with the help of PCI Ventures.
Pennovation Accelerator’s 2021 Pitch Day
In August 2021, the Pennovation Accelerator, an annual six week program that teaches local startups about business development, named two winners for its Pitch Day event.